Flash
›
Fusion Antibodies plc (FAB.L) Deep Dive Video
Fusion Antibodies plc (FAB.L) Deep Dive Video
Summary
Fusion Antibodies is a high-risk AIM micro-cap turnaround where OptiMAL® licensing could unlock asymmetric upside, but weak cash flow, dilution risk, and uncertain commercial adoption remain decisive hurdles.
View FAB.L stock page
·
Read the FAB.L research report
Loading the video player…
Loading Flash…